NO151621C - Analogifremgangsmaate for fremstilling av cytostatisk, hypotensivt og analgetisk aktive cykliske dobbelte hemiacetaler av endiolforbindelser - Google Patents

Analogifremgangsmaate for fremstilling av cytostatisk, hypotensivt og analgetisk aktive cykliske dobbelte hemiacetaler av endiolforbindelser

Info

Publication number
NO151621C
NO151621C NO800958A NO800958A NO151621C NO 151621 C NO151621 C NO 151621C NO 800958 A NO800958 A NO 800958A NO 800958 A NO800958 A NO 800958A NO 151621 C NO151621 C NO 151621C
Authority
NO
Norway
Prior art keywords
hemiacetals
hypotensive
cytostatic
preparation
active cyclic
Prior art date
Application number
NO800958A
Other languages
English (en)
Norwegian (no)
Other versions
NO800958L (no
NO151621B (no
Inventor
Gabor B Fodor
Albert Szent-Gyoergyi
Original Assignee
Cancer Res Nat Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Nat Found filed Critical Cancer Res Nat Found
Publication of NO800958L publication Critical patent/NO800958L/no
Publication of NO151621B publication Critical patent/NO151621B/no
Publication of NO151621C publication Critical patent/NO151621C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
NO800958A 1979-04-06 1980-04-01 Analogifremgangsmaate for fremstilling av cytostatisk, hypotensivt og analgetisk aktive cykliske dobbelte hemiacetaler av endiolforbindelser NO151621C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/027,692 US4238500A (en) 1979-04-06 1979-04-06 Cyclic double hemiacetals of enediol compounds and compositions and methods for preparing and using same

Publications (3)

Publication Number Publication Date
NO800958L NO800958L (no) 1980-10-07
NO151621B NO151621B (no) 1985-01-28
NO151621C true NO151621C (no) 1985-05-08

Family

ID=21839228

Family Applications (1)

Application Number Title Priority Date Filing Date
NO800958A NO151621C (no) 1979-04-06 1980-04-01 Analogifremgangsmaate for fremstilling av cytostatisk, hypotensivt og analgetisk aktive cykliske dobbelte hemiacetaler av endiolforbindelser

Country Status (15)

Country Link
US (1) US4238500A (it)
JP (1) JPS5649375A (it)
AU (1) AU521764B2 (it)
CA (1) CA1167859A (it)
CH (1) CH643550A5 (it)
DE (1) DE3010947C2 (it)
DK (1) DK150780A (it)
FR (1) FR2453171A1 (it)
GB (1) GB2061259B (it)
HU (1) HU182119B (it)
IE (1) IE49434B1 (it)
IT (1) IT1141269B (it)
NL (1) NL8001603A (it)
NO (1) NO151621C (it)
SE (1) SE448236B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518611A (en) * 1983-04-04 1985-05-21 National Foundation For Cancer Research, Inc. 2-Furylbutyrolactone modulation of the immune system in mammals
DE3781366T2 (de) * 1986-04-29 1993-01-07 Theracel Corp Herstellung und verwendung eines reaktionsprodukts aus ascorbinsaeure mit alpha,beta-ungesaettigtem keton oder vinyl-aliphatischem keton.
DE3826303A1 (de) * 1988-08-03 1990-02-08 Basf Ag Verfahren zur herstellung cyclischer 6- bis 8-gliedriger vinylen-1,2-dioxyverbindungen
US6001347A (en) * 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US8163796B1 (en) 2009-07-28 2012-04-24 BioChemical Solutions, LLC Treatment of cancer by oxidation-reduction potentiation of cancerostatic dicarbonyls

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3048598A (en) * 1960-02-23 1962-08-07 Miles Lab Process for producing 2-hydrocarbon-2-dioxenes
US3555006A (en) * 1967-06-15 1971-01-12 Exxon Production Research Co Polysaccharide polymer cyclic ketals
GB1270579A (en) * 1968-08-17 1972-04-12 Fuji Photo Film Co Ltd Dihydroxy-1,4-dioxanes
BE759354A (fr) * 1969-11-28 1971-04-30 Fuji Photo Film Co Ltd Preparation de dihydroxy-1,4-dioxannes
US4096321A (en) * 1976-11-22 1978-06-20 Hoffmann-La Roche Inc. Process to produce oxazinomycin and intermediates
NL7904249A (nl) * 1978-06-20 1979-12-27 Cancer Res Nat Found Nieuwe cyclische acetalen met cytostatische, bloed- drukverlagende en pijnstillende werking, werkwijze ter bereiding van deze verbindingen alsmede farmaceu- tische preparaten die een dergelijke verbinding bevat- ten.

Also Published As

Publication number Publication date
IT8021166A0 (it) 1980-04-03
FR2453171A1 (fr) 1980-10-31
NO800958L (no) 1980-10-07
IE800626L (en) 1980-10-06
SE448236B (sv) 1987-02-02
DE3010947A1 (de) 1980-10-23
CH643550A5 (de) 1984-06-15
AU521764B2 (en) 1982-04-29
GB2061259B (en) 1983-02-02
IT1141269B (it) 1986-10-01
DE3010947C2 (de) 1986-08-07
IE49434B1 (en) 1985-10-02
AU5703780A (en) 1980-10-09
HU182119B (en) 1983-12-28
NL8001603A (nl) 1980-10-08
NO151621B (no) 1985-01-28
FR2453171B1 (it) 1983-04-08
US4238500A (en) 1980-12-09
GB2061259A (en) 1981-05-13
SE8002549L (sv) 1980-10-07
DK150780A (da) 1980-10-07
CA1167859A (en) 1984-05-22
JPS5649375A (en) 1981-05-02

Similar Documents

Publication Publication Date Title
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO152899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater.
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO154521C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive piperidinderivater.
NO149923C (no) Analogifremgangsmaate for fremstlling av fysiologisk aktive prolinderivater
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO157146C (no) Analogifremgangsmaate ved fremstilling av terapeutisk, aktive derivater av morfolinyl-daunorbicin og morfolinyl-doksorubicin.
NO153496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO165922C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO148416C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-, morfolin- og tiazan-derivater
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO149428C (no) Fremgangsmaate for fremstilling av fysiologisk aktive prostaglandinderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
NO151621C (no) Analogifremgangsmaate for fremstilling av cytostatisk, hypotensivt og analgetisk aktive cykliske dobbelte hemiacetaler av endiolforbindelser
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.